Press Releases

New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

On May 4, 2023, Lonza Bioscience Informatics will present a free 45-minute webinar that includes a discussion with Dr Phanesh Koneru, CEO, Exela® Pharma Sciences.

Onyx Scientific increases non-GMP capabilities with CMC facility expansion

BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets

Elligo Health Research Opens New, Larger Clinical Research Center in Austin

Elligo Health Research®, the largest healthcare-enabling research organization, has opened its new clinical research center in Austin, Texas.

AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs

AARDEX Group Partners with Industry Leaders on DiMe’s V3+ Framework Project to Enhance Usability of DHTs Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework Project will ensure digital clinical measures and products meet the needs of larger audiences.

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor

CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor Registration for must-attend Risk-Based Quality Management event is now open

Arranta Bio, a Recipharm company, signs contract with MIT to develop rapid manufacturing of mRNA therapeutics

Headlands Research Acquires Clinvest Research — the Clinical Research Site Network’s Third Addition of 2023

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of Clinvest Research, an established site based in Springfield, Missouri. Founded in 1996, Clinvest Research has conducted over 600 trials for chronic diseases and conditions such as headache and migraine, arthritis and chronic pain, and diabetes, as well as weight loss. “The acquisition of Clinvest Research strengthens our chronic pain and endocrinology expertise and increases participant access to clinical trials for highly prevalent diseases and conditions that often remain undiagnosed and untreated,” said Cathy Collins, CEO of Headlands Research.

Improving Clinical Data Management: Challenges, Solutions, and Future Trends

Unlock the power of clinical data management for accurate research and better Clinical research outcomes. Discover the key components, technology advancements, and benefits in this essential field.

BOC Sciences Reports Strong Capabilities of CDMO Operations

BOC Sciences, one of the front-runners in chemical material manufacturing and custom services for the full drug product lifecycle, today reported strong growth over the past year in its expanded contract development and manufacturing (CDMO) platform.

Saudia Cargo agreement with Tower Cold Chain extends choice in Middle East pharmaceutical shipments

Saudia Cargo has added Tower Cold Chain to its approved roster of temperature-controlled containers for shipping pharmaceutical, biotech and life science products, in a new global rental agreement.

Enhancing Clinical Trials: The Benefits of Electronic Data Capture (EDC)

Discover how Electronic Data Capture (EDC) revolutionizes clinical trials by streamlining data collection, improving accuracy, and ensuring compliance. Explore the advantages of EDC and its impact on efficient clinical research.

BOC Sciences Ensures Secure and Rapid Delivery of Isotopically Labeled Materials for Drug Compound Development

BOC Sciences' radiochemists work closely with the worldwide drug compound research teams to deliver high-quality stable isotope labeled products as well as consulting and tailor-made services.

ISCT Reaffirms Position on Addressing Ethical Implications of US Expanded Access Pathway

International Society for Cell & Gene Therapy Publishes Report Exploring Areas for Potential Misuse and Outlines Plans for Future Guidelines to Keep Patients Safe

Tower Cold Chain adds 2023 King's Award for Innovation to last year's Queen's Award

Tower Cold Chain, pharmaceutical container specialist, has been awarded the prestigious King’s Award for Enterprise, in the Innovation category – adding to the Queen’s Award for International Trade the company won in 2022.

Upperton increases oral dosage form capabilities at its Nottingham HQ

CureSearch to fund new cutting-edge study for rare blood cancer in children

Elvin Wagenblast, PhD, of The Tisch Cancer Institute at Mount Sinai, received a CureSearch Young Investigator Award to develop a better understanding of AML in order to guide treatment for patients where standard chemotherapy is ineffective. The study is investigating how a normal blood stem cell can become cancerous. Dr. Wagenblast’s team is using state-of-the-art genome editing to understand vulnerabilities of the disease like never before.

Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases

Headlands Research, a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts. The site has specialized in neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease for over 25 years. This acquisition deepens Headland Research's existing expertise in neurology.

Molecular and digital pathology innovators Xyall and Indica Labs forge global collaboration to transform precision oncology workflows

Indica Labs has announced a global strategic partnership with Xyall to bridge the gap between histology and molecular pathology.

Microbiosci Has Established Automated Microbial Strains Breeding and Screening Platform